急诊科胸部CT诊断COVID-19肺炎:荷兰经验
这项回顾性多中心研究纳入2020年3月至4月六家医疗中心急诊科1070例疑似COVID-19的中重度上呼吸道症状患者,采用CO-RADS评分解读胸部CT并与RT-PCR及临床参考标准比较。CT对RT-PCR和临床参考标准的AUC均为0.87(95%CI: 0.84, 0.89和0.85, 0.89),CO-RADS≥4分诊断COVID-19的OR为25.9(95%CI: 18.7, 35.9)和30.6(95%CI: 21.1, 44.4)。症状持续时间小于48小时时AUC降至0.71(95%CI: 0.62, 0.80;P < .001)。
要点
- CO-RADS≥4分诊断COVID-19的OR为25.9(95%CI: 18.7, 35.9)和30.6(95%CI: 21.1, 44.4)。
- CT对RT-PCR和临床参考标准的AUC均为0.87(95%CI: 0.84, 0.89和0.85, 0.89)。
- 症状持续时间小于48小时时AUC降至0.71(95%CI: 0.62, 0.80;P < .001)。
核心结论
- 使用CO-RADS评分分析胸部CT可快速可靠地诊断COVID-19,尤其是症状持续时间大于48小时时。
研究设计与样本
- 回顾性多中心研究,纳入2020年3月至4月六家医疗中心急诊科1070例疑似COVID-19的中重度上呼吸道症状连续患者。
关键影像表现/征象
- 胸部CT采用五点CO-RADS评分方案评估COVID-19怀疑程度。
- CT与SARS-CoV-2 RT-PCR及基于RT-PCR、接触史、氧疗、检测时机和可能替代诊断的多学科临床参考标准比较。
诊断标准与关键数值
- CT对RT-PCR的AUC为0.87(95%CI: 0.84, 0.89),对临床参考标准的AUC为0.87(95%CI: 0.85, 0.89)。
- CO-RADS≥4分对RT-PCR诊断COVID-19的OR为25.9(95%CI: 18.7, 35.9),对临床参考标准的OR为30.6(95%CI: 21.1, 44.4)。
- 症状持续时间小于48小时时AUC为0.71(95%CI: 0.62, 0.80;P < .001)。
临床应用与阅片要点
- 放射科急诊胸部CT采用CO-RADS评分解读,CO-RADS≥4分提示COVID-19诊断可能性高。
- 症状持续时间大于48小时时CT诊断性能较好,小于48小时时AUC降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Clinicians need to rapidly and reliably diagnose coronavirus disease 2019 (COVID-19) for proper risk stratification, isolation strategies, and treatment decisions. Purpose To assess the real-life performance of radiologist emergency department chest CT interpretation for diagnosing COVID-19 during the acute phase of the pandemic, using the COVID-19 Reporting and Data System (CO-RADS). Materials and Methods This retrospective multicenter study included consecutive patients who presented to emergency departments in six medical centers between March and April 2020 with moderate to severe upper respiratory symptoms suspicious for COVID-19. As part of clinical practice, chest CT scans were obtained for primary work-up and scored using the five-point CO-RADS scheme for suspicion of COVID-19. CT was compared with severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction (RT-PCR) assay and a clinical reference standard established by a multidisciplinary group of clinicians based on RT-PCR, COVID-19 contact history, oxygen therapy, timing of RT-PCR testing, and likely alternative diagnosis. Performance of CT was estimated using area under the receiver operating characteristic curve (AUC) analysis and diagnostic odds ratios against both reference standards. Subgroup analysis was performed on the basis of symptom duration grouped presentations of less than 48 hours, 48 hours through 7 days, and more than 7 days. Results A total of 1070 patients (median age, 66 years; interquartile range, 54-75 years; 626 men) were included, of whom 536 (50%) had a positive RT-PCR result and 137 (13%) of whom were considered to have a possible or probable COVID-19 diagnosis based on the clinical reference standard. Chest CT yielded an AUC of 0.87 (95% CI: 0.84, 0.89) compared with RT-PCR and 0.87 (95% CI: 0.85, 0.89) compared with the clinical reference standard. A CO-RADS score of 4 or greater yielded an odds ratio of 25.9 (95% CI: 18.7, 35.9) for a COVID-19 diagnosis with RT-PCR and an odds ratio of 30.6 (95% CI: 21.1, 44.4) with the clinical reference standard. For symptom duration of less than 48 hours, the AUC fell to 0.71 (95% CI: 0.62, 0.80; P < .001). Conclusion Chest CT analysis using the coronavirus disease 2019 (COVID-19) Reporting and Data System enables rapid and reliable diagnosis of COVID-19, particularly when symptom duration is greater than 48 hours. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Elicker in this issue.
引用
- Schalekamp S, Bleeker-Rovers CP, Beenen LFM, et al. Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience. Radiology. 2020. PMID: 33201791. doi:10.1148/radiol.2020203465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。